{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:47:33Z","timestamp":1776296853492,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"},{"name":"ARCS Foundation, Inc., Los Angeles founder chapter-Margaret Kersten Ponty Postdoctoral Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00404-019-05059-2","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T10:02:33Z","timestamp":1548928953000},"page":"801-808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia"],"prefix":"10.1007","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-5109","authenticated-orcid":false,"given":"Marcia A.","family":"Ciccone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte L.","family":"Conturie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niquelle","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina E.","family":"Dancz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begum","family":"\u00d6zel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"5059_CR1","first-page":"7","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA. 68:7\u201330","journal-title":"CA."},{"key":"5059_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","volume":"56","author":"RJ Kurman","year":"1985","unstructured":"Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients. Cancer 56:403\u2013412","journal-title":"Cancer"},{"key":"5059_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cncr.21650","volume":"106","author":"CL Trimble","year":"2006","unstructured":"Trimble CL, Kauderer J, Zaino R et al (2006) Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 106:812\u2013819","journal-title":"Cancer"},{"key":"5059_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ygyno.2015.07.108","volume":"139","author":"K Matsuo","year":"2015","unstructured":"Matsuo K, Ramzan AA, Gualtieri MR et al (2015) Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol 139:261\u2013267","journal-title":"Gynecol Oncol"},{"key":"5059_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-0029-1242998","volume":"28","author":"JJ Kim","year":"2010","unstructured":"Kim JJ, Chapman-Davis E (2010) Role of progesterone in endometrial cancer. Semin Reprod Med. 28:81\u201390","journal-title":"Semin Reprod Med."},{"key":"5059_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/AOG.0000000000001071","volume":"126","author":"VFO Parkash","year":"2015","unstructured":"Parkash VFO, Tornos C, McCluggage WG (2015) Committee opinion no. 631: endometrial intraepithelial neoplasia. Obstet Gynecol. 126:897","journal-title":"Obstet Gynecol."},{"key":"5059_CR7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","volume":"120","author":"CL Trimble","year":"2012","unstructured":"Trimble CL, Method M, Leitao M, Lu K, Society of Gynecologic Oncology Clinical Practice Committee et al (2012) Management of endometrial precancers. Obstet Gynecol 120:1160\u20131175","journal-title":"Obstet Gynecol"},{"key":"5059_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/aje\/kwn168","volume":"168","author":"M Epplein","year":"2008","unstructured":"Epplein M, Reed SD, Voigt LF et al (2008) Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am J Epidemiol. 168:563\u2013570 (discussion 71\u20136)","journal-title":"Am J Epidemiol."},{"key":"5059_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, Carroll MD, Ogden CL et al (2010) PRevalence and trends in obesity among us adults, 1999\u20132008. JAMA 303:235\u2013241","journal-title":"JAMA"},{"key":"5059_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.contraception.2010.01.016","volume":"81","author":"CL Westhoff","year":"2010","unstructured":"Westhoff CL, Torgal AH, Mayeda ER et al (2010) Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception. 81:474\u2013480","journal-title":"Contraception."},{"key":"5059_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2165\/00003088-200039030-00004","volume":"39","author":"G Cheymol","year":"2012","unstructured":"Cheymol G (2012) Effects of obesity on pharmacokinetics. Clin Pharmacokinet 39:215\u2013231","journal-title":"Clin Pharmacokinet"},{"key":"5059_CR12","doi-asserted-by":"publisher","first-page":"85S","DOI":"10.1016\/S0010-7824(98)00120-6","volume":"58","author":"J Huber","year":"1998","unstructured":"Huber J (1998) Pharmacokinetics of Implanon. Contraception. 58:85S\u201390S","journal-title":"Contraception."},{"key":"5059_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","volume":"64","author":"I Sivin","year":"2001","unstructured":"Sivin I, Wan L, Ranta S et al (2001) Levonorgestrel concentrations during 7\u00a0years of continuous use of Jadelle contraceptive implants. Contraception. 64:43\u201349","journal-title":"Contraception."},{"key":"5059_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0010-7824(99)00085-2","volume":"60","author":"MH Rahimy","year":"1999","unstructured":"Rahimy MH, Cromie MA, Hopkins NK, Tong DM (1999) Lunelle(TM) monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics. Contraception. 60:201\u2013208","journal-title":"Contraception."},{"key":"5059_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ygyno.2015.12.010","volume":"140","author":"D Cholakian","year":"2016","unstructured":"Cholakian D, Hacker K, Fader AN et al (2016) Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer. Gynecol Oncol 140:234\u2013238","journal-title":"Gynecol Oncol"},{"key":"5059_CR16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/AOG.0b013e31828cb563","volume":"121","author":"ID Gallos","year":"2013","unstructured":"Gallos ID, Ganesan R, Gupta JK (2013) Prediction of regression and relapse of endometrial hyperplasia with conservative therapy. Obstet Gynecol 121:1165\u20131171","journal-title":"Obstet Gynecol"},{"key":"5059_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0002-9378(12)90884-4","volume":"168","author":"GCYN Rodriguez","year":"1993","unstructured":"Rodriguez GCYN, King ME (1993) A comparison of the Pipelle device and the Vabra aspirator as measured by endometrial denudation in hysterectomy specimens: the Pipelle device samples significantly less of the endometrial service than the Vabra aspirator. Am J Obstet Gynecol 168:55\u201359","journal-title":"Am J Obstet Gynecol"},{"key":"5059_CR18","volume-title":"World Health Organisation classification of tumors of female reproductive organs","year":"2014","unstructured":"Kurman RCM, Herrington C et al (eds) (2014) World Health Organisation classification of tumors of female reproductive organs, 4th edn. International Agency for Research on Cancer (IARC), Lyon","edition":"4"},{"key":"5059_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.007","volume":"133","author":"C Gonthier","year":"2014","unstructured":"Gonthier C, Walker F, Luton D et al (2014) Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer. Gynecol Oncol 133:33\u201337","journal-title":"Gynecol Oncol"},{"key":"5059_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.contraception.2012.10.008","volume":"87","author":"AB Edelman","year":"2013","unstructured":"Edelman AB, Cherala G, Munar MY et al (2013) Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception. 87:220\u2013226","journal-title":"Contraception."},{"key":"5059_CR21","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/oby.2010.35","volume":"18","author":"MM Huizinga","year":"2010","unstructured":"Huizinga MM, Bleich SN, Beach MC et al (2010) Disparity in physician perception of patients\u2019 adherence to medications by obesity status. Obesity. 18:1932\u20131937","journal-title":"Obesity."},{"key":"5059_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/13625187.2014.951433","volume":"20","author":"W Modesto","year":"2015","unstructured":"Modesto W, Correia VM, Borges L et al (2015) Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use. Eur J Contracept Reprod Health Care. 20:57\u201363","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"5059_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","volume":"131","author":"N Pal","year":"2018","unstructured":"Pal N, Broaddus RR, Urbauer DL et al (2018) Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device. Obstet Gynecol 131:109\u2013116","journal-title":"Obstet Gynecol"},{"key":"5059_CR24","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","volume":"367","author":"SF Nielsen","year":"2012","unstructured":"Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367:1792\u20131802","journal-title":"N Engl J Med"},{"key":"5059_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ygyno.2017.10.026","volume":"148","author":"T Takiuchi","year":"2018","unstructured":"Takiuchi T, Blake EA, Matsuo K et al (2018) Aspirin use and endometrial cancer risk and survival. Gynecol Oncol 148:222\u2013232","journal-title":"Gynecol Oncol"},{"key":"5059_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ygyno.2017.07.120","volume":"147","author":"CG Meireles","year":"2017","unstructured":"Meireles CG, Pereira SA, Valadares LP et al (2017) Effects of metformin on endometrial cancer: systematic review and meta-analysis. Gynecol Oncol 147:167\u2013180","journal-title":"Gynecol Oncol"},{"key":"5059_CR27","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1002\/cncr.29392","volume":"121","author":"JL Watkins","year":"2015","unstructured":"Watkins JL, Thacker PH, Nick AM et al (2015) Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer 121:3444\u20133451","journal-title":"Cancer"},{"key":"5059_CR28","doi-asserted-by":"publisher","first-page":"547.e1","DOI":"10.1016\/j.ajog.2010.07.037","volume":"203","author":"ID Gallos","year":"2010","unstructured":"Gallos ID, Shehmar M, Thangaratinam S et al (2010) Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstetr Gynecol. 203:547.e1\u2013547.e10","journal-title":"Am J Obstetr Gynecol."},{"key":"5059_CR29","doi-asserted-by":"publisher","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","volume":"207","author":"ID Gallos","year":"2012","unstructured":"Gallos ID, Yap J, Rajkhowa M et al (2012) Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstetr Gynecol. 207:266.e1\u2013266.e12","journal-title":"Am J Obstetr Gynecol."},{"key":"5059_CR30","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.3802\/jgo.2016.27.e8","volume":"27","author":"V Chandra","year":"2016","unstructured":"Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R (2016) Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol 27:e8","journal-title":"J Gynecol Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-019-05059-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05059-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05059-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T22:01:14Z","timestamp":1606341674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-019-05059-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["5059"],"URL":"https:\/\/doi.org\/10.1007\/s00404-019-05059-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Honorarium, Chugai (K.M.) not related to this study; none for others.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study involving human participants performed by authors is approved by Institutional Review Board, University of Southern California. This retrospective study of archived medical records waived to obtain informed consents from study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}